Abstract
90Y radioembolization is a safe and efficacious treatment option for many patients with unresectable hepatocellular carcinoma. Potential candidates for radioembolization, based on clinical criteria, undergo 99mTc-labeled macroaggregated albumin imaging to determine the extent of hepatopulmonary shunting. Dose selection is based on results from shunt imaging and can exclude patients from radioembolization therapy. We present a case of miscalculated lung shunt fraction and the circumstances that led to the critical error.
Original language | English (US) |
---|---|
Pages (from-to) | 184-186 |
Number of pages | 3 |
Journal | Journal of nuclear medicine technology |
Volume | 48 |
Issue number | 2 |
DOIs | |
State | Published - Jun 1 2020 |
Keywords
- Hepatocellular carcinoma
- Lung shunt fraction
- Tc-labeled macroaggregated albumin
- Y radioembolization
ASJC Scopus subject areas
- General Medicine